How much does Ubrelvy cost with insurance?
The cost of Ubrelvy with insurance can vary significantly based on a patient's specific health plan. Many insurance plans offer coverage for Ubrelvy, which can substantially reduce out-of-pocket expenses. However, the final price is determined by factors such as deductibles, copayments, and whether Ubrelvy is preferred on the plan's formulary [1].
What is the list price of Ubrelvy?
The list price, or wholesale acquisition cost, for Ubrelvy is approximately $1,200 for a 30-count supply of 100 mg tablets and around $600 for a 30-count supply of 50 mg tablets [2]. This price does not reflect what patients will pay, as insurance and savings cards can lower the cost.
Are there Ubrelvy savings programs available?
Yes, eligible commercially insured patients may be able to reduce their out-of-pocket costs for Ubrelvy through manufacturer savings programs. The Ubrelvy Savings Card can potentially lower the cost to as little as $20 per prescription for a 30-day supply [1][3]. There are also limits on the maximum savings available per prescription and program participation.
What if my insurance doesn't cover Ubrelvy?
If a patient's insurance plan does not cover Ubrelvy, or if they have high out-of-pocket costs, they may explore alternative options. These could include patient assistance programs or inquiring about the availability of alternative migraine treatments that may be covered by their insurance [1].
How does Ubrelvy work for migraines?
Ubrelvy (ubrogepant) is an oral medication used to treat acute migraine attacks. It works by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule that is thought to play a role in migraine pain. By inhibiting CGRP, Ubrelvy helps to reduce inflammation and pain associated with migraines [4].
When does Ubrelvy's patent expire?
Information regarding Ubrelvy's patent expiration dates is available through specialized drug patent databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can include details on exclusivity periods and potential patent challenges that could affect market entry for generic alternatives [5].
Who manufactures Ubrelvy?
Ubrelvy is manufactured by AbbVie [4].
What are the side effects of Ubrelvy?
Common side effects of Ubrelvy include nausea, fatigue, and dry mouth [4]. Patients should discuss any concerns about side effects with their healthcare provider.
Sources:
[1] https://www.ubrelvy.com/savings-and-support
[2] https://www.ubrelvy.com/cost-and-savings
[3] https://www.ubrelvy.com/patient-support
[4] https://www.ubrelvy.com/
[5] https://drugpatentwatch.com/